KMT2A and leukemia: Indeed, treatment with AS-99 resulted in a reduced number of H3K36me2 peaks when compared to the DMSO-treated cells, confirming that AS-99 blocks the enzymatic activity of ASH1L in the MLL1-rearranged leukemia cells (Fig. 5g).